​AmeriHealth HMO, Inc., AmeriHealth Insurance Company of New Jersey, and AmeriHealth Administrators updated several policies last month. Updated policies include:

• Commercial: #08.01.79d: Dostarlimab-gxly (Jemperli). Effective and published: March 13, 2023.
• Commercial: #08.01.94b nivolumab and relatlimab-rmbw (Opdualag™). Effective and published: March 13, 2023.

To see specific policy changes, click on the policy name and scroll down to Policy History. To view the latest medical and claim payment policy bulletins, visit the Medical and Claim Payment Policy Portal.

For important policy information related to COVID-19, visit the News & Announcements section of the portal.